ライフサイエンスコーパス: basic fibroblast growth factor

1 roblast growth factor 2 (also referred to as basic fibroblast growth factor).

2 evascularization of the graft bed by agarose-basic fibroblast growth factor.

3 PC12 cells, but not outgrowth stimulated by basic fibroblast growth factor.

4 proliferation in the presence and absence of basic fibroblast growth factor.

5 n, but does not alter fibrocyte responses to basic fibroblast growth factor.

6 which was markedly induced by TGF-beta, and basic fibroblast growth factor.

7 inor (truncated discoidin-I-like domain), or basic fibroblast growth factor.

8 , Del-1 doubled fibrovascular growth, as did basic fibroblast growth factor.

9 ed by vascular endothelial growth factor and basic fibroblast growth factor.

10 ses to vascular endothelial growth factor or basic fibroblast growth factor.

11 (HMVECs), with potency comparable to that of basic fibroblast growth factor.

12 ment with phorbol 12-myristate 13-acetate or basic fibroblast growth factor.

13 EC to vascular endothelial growth factor or basic fibroblast growth factor.

14 upregulated autophagy through IL6, IL8, and basic fibroblast growth factor.

15 d decreased secretion of VEGF-A, VEGF-C, and basic fibroblast growth factor.

16 edium containing epidermal growth factor and basic fibroblast growth factor.

17 s preceded by a local increase in VEGF-A and basic fibroblast growth factor.

18 ated by calcitriol, parathyroid hormone, and basic-fibroblast growth factor.

19 expressed elevated phospho-Akt (1.85-fold), basic fibroblast growth factor (1.44-fold), hepatocyte g

20 lin-like growth factor 1 (IGF-1), as well as basic fibroblast growth factor 2 (bFGF2), reportedly ast

21 xenograft tumor models as well as suppresses basic fibroblast growth factor 2 (FGF-2)-induced neovasc

22 Although exogenous basic fibroblast growth factor 2 (FGF-2/Fgf-2) is common

23 , and we established a role for ASMC-derived basic fibroblast growth factor 2 (FGF2b) and FGF recepto

24 on of vascular endothelial growth factor and basic fibroblast growth factor-2 mRNA transcripts in isc

25 According to this model, basic fibroblast growth factor, a mammary differentiatio

26 d neurospheres, divided in response to bFGF (basic fibroblast growth factor), activated the neuroepit

27 Basic fibroblast growth factor activation of the ERK pat

28 ced by vascular endothelial growth factor or basic fibroblast growth factor administration.

29 her angiogenic proteins including acidic and basic fibroblast growth factors (aFGF and bFGF), epiderm

30 photoaptamers 0650 and 0615 cross-link human basic fibroblast growth factor and 0518 cross-links HIV

31 morphogenetic protein-4 in combination with basic fibroblast growth factor and activin A results in

32 A direct link between PTTG, basic fibroblast growth factor and angiogenesis has been

33 We show that NFATc2 is also activated by basic fibroblast growth factor and blocked by the inhibi

34 stimulated by keratinocyte growth factor and basic fibroblast growth factor and growth-inhibited by a

35 ogenic and proinflammatory cytokines such as basic fibroblast growth factor and IL-1, endothelial cel

36 sponges containing 0.4% agarose and IL-6 or basic fibroblast growth factor and implanted into the su

37 r PTKs for insulin, epidermal growth factor, basic fibroblast growth factor and insulin-like growth f

38 dhesion molecule [ICAM], and E-selectin) and basic fibroblast growth factor and outcome.

39 t in the absence of serum the combination of basic fibroblast growth factor and platelet-derived grow

40 wth response protein 1 and its target genes, basic fibroblast growth factor and platelet-derived grow

41 vitro angiogenesis assay, c7E3 Fab inhibited basic fibroblast growth factor and platelet-stimulated c

42 sin S- or cystatin C-null mice, tumor tissue basic fibroblast growth factor and serum type 1 insulin

43 Basic fibroblast growth factor and SMOC-2 elicited a syn

44 sed association with eIF4E and inhibition of basic fibroblast growth factor and vascular endothelial

45 mor and that it directly inhibits binding of basic fibroblast growth factor and vascular endothelial

46 igration and blocked angiogenesis induced by basic fibroblast growth factor and vascular endothelial

47 actors were detected in EGFP+ CBSCs in vivo (basic fibroblast growth factor and vascular endothelial

48 ation, and tube formation, the regulation of basic fibroblast growth factor and vascular endothelial

49 r growth factors identified, including VEGF, basic fibroblast growth factor, and brain-derived neurot

50 HUVECs and the angiogenic response to VEGF, basic fibroblast growth factor, and epidermal growth fac

51 es, including epidermal growth factor (EGF), basic fibroblast growth factor, and hepatocyte growth fa

52 such as vascular endothelial growth factor, basic fibroblast growth factor, and hepatocyte growth fa

53 endothelial growth factor, stem cell factor, basic fibroblast growth factor, and interleukin 6.

54 ncluding vascular endothelial growth factor, basic fibroblast growth factor, and interleukin-8, has b

55 edullin, vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived gro

56 hemotactic factors including angiotensin II, basic fibroblast growth factor, and platelet-derived gro

57 in the mouse cornea using 80 ng of purified basic fibroblast growth factor, and the neovascular resp

58 angiogenic factors, including interleukin 8, basic fibroblast growth factor, and vascular endothelial

59 ference and neutralization of interleukin-8, basic fibroblast growth factor, and vascular endothelial

60 ole of isoforms of protein kinase C (PKC) in basic fibroblast growth factor- and interleukin-1alpha-m

61 Thrombopoietin and basic fibroblast growth factor are identified as critica

62 Most of the basic fibroblast growth factor-arrested cells fail to es

63 s activated by nerve growth factor (NGF) and basic fibroblast growth factor as well as by the guanine

64 encoding fibroblast growth factor 2 (Fgf2 or basic fibroblast growth factor) as a target gene that is

65 ukin-6 (vIL-6) in vitro and VEGF, vIL-6, and basic-fibroblast growth factor (b-FGF) in mouse xenograf

66 GF activity by the seminal observations that basic fibroblast growth factor (bFGF or FGF-2) required

67 Neurotrophic factors, such as basic fibroblast growth factor (bFGF or FGF2), are neces

68 ment with either the angiogenesis stimulator basic fibroblast growth factor (bFGF) (1 microg/g/d intr

69 We have found that the basic fibroblast growth factor (bFGF) accumulates in the

70 nt JB6 mouse epidermal cells stimulated with basic fibroblast growth factor (bFGF) and 12-O-tetradeca

71 potent embryonic stem (ES) cells cultured in basic fibroblast growth factor (bFGF) and activin A deve

72 ascular endothelial growth factor A (VEGFA), basic fibroblast growth factor (bFGF) and angiogenin (AN

73 tance contractions with two candidate mRNAs, basic fibroblast growth factor (bFGF) and elongation fac

74 In neural stem cells, basic fibroblast growth factor (bFGF) and epidermal grow

75 were cultured in the presence or absence of basic fibroblast growth factor (bFGF) and exposed to ion

76 Basic fibroblast growth factor (bFGF) and its major rece

77 on is associated with elevated production of basic fibroblast growth factor (bFGF) and matrix metallo

78 Elevated expression of basic fibroblast growth factor (bFGF) and matrix metallo

79 determined the optimal concentration of both basic fibroblast growth factor (bFGF) and neuregulin-1 b

80 ed whether the heparin-binding growth factor basic fibroblast growth factor (bFGF) and one of its rec

81 Direct immunoassays for detecting basic fibroblast growth factor (bFGF) and prostate-speci

82 heparan sulfate proteoglycans that can bind basic fibroblast growth factor (bFGF) and serum amyloid

83 However, growth factors such as basic fibroblast growth factor (bFGF) and vascular endot

84 Here, we show that basic fibroblast growth factor (bFGF) and vascular endot

85 We assessed the effects of basic fibroblast growth factor (bFGF) and vascular endot

86 Binding of basic fibroblast growth factor (bFGF) and vascular endot

87 ions were not changed by surgical delay, but basic fibroblast growth factor (bFGF) and VEGF expressio

88 t YKL40 displaced extracellular matrix-bound basic fibroblast growth factor (bFGF) as well as inhibit

89 Excessive release of basic fibroblast growth factor (bFGF) during loading and

90 Here we wished to ascertain whether basic fibroblast growth factor (bFGF) enhances axonal br

91 The hTERT-immortalized cells divided in basic fibroblast growth factor (bFGF) expressed high tel

92 Hepatocyte growth factor (HGF) and basic fibroblast growth factor (bFGF) expression was mea

93 pression) was decreased significantly, while basic fibroblast growth factor (bFGF) expression, a know

94 Withdrawal of basic fibroblast growth factor (bFGF) from the culture i

95 Of all factors tested, the basic fibroblast growth factor (bFGF) had the most signi

96 Basic fibroblast growth factor (bFGF) has shown promise

97 as insulin-like growth factor 1 (IGF-1) and basic fibroblast growth factor (bFGF) have been shown to

98 Cs) (p<0.01) and the angiogenesis induced by basic fibroblast growth factor (bFGF) in a Matrigel plug

99 NSCs exposed to basic fibroblast growth factor (bFGF) in vitro generated

100 ascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) increase SDF-1 exp

101 ascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) increases the expr

102 Basic fibroblast growth factor (bFGF) induces cell death

103 Basic fibroblast growth factor (bFGF) is a potent mitoge

104 Basic fibroblast growth factor (bFGF) is a protein that

105 Since basic fibroblast growth factor (bFGF) is a survival fact

106 Basic fibroblast growth factor (bFGF) is an angiogenic p

107 Basic fibroblast growth factor (bFGF) may protect stroke

108 ession of APN and its receptors, HB-EGF, and basic fibroblast growth factor (bFGF) messenger RNA was

109 Basic fibroblast growth factor (bFGF) modulates gingival

110 We studied the effect of local delivery of basic fibroblast growth factor (bFGF) on angiogenesis an

111 FXa are inhibited by antibodies neutralizing basic fibroblast growth factor (bFGF) or by heparin.

112 fold differences in responsiveness to either basic fibroblast growth factor (bFGF) or vascular endoth

113 By basic fibroblast growth factor (bFGF) or vascular endoth

114 Stimulation by basic fibroblast growth factor (bFGF) or vascular endoth

115 lant contained 0.5, 1.0, or 1.5 microg human basic fibroblast growth factor (bFGF) per milliliter of

116 asing ciliary neurotrophic factor (CNTF) and basic fibroblast growth factor (bFGF) production in Mull

117 broblasts (PDLFs) in terms of proliferation, basic fibroblast growth factor (bFGF) release, collagen

118 Basic fibroblast growth factor (bFGF) released from a na

119 n, migration, capillary-like tube formation, basic fibroblast growth factor (bFGF) signaling, and per

120 onse to epidermal growth factor (EGF) and/or basic fibroblast growth factor (bFGF) stimulation.

121 We have shown that basic fibroblast growth factor (bFGF) supplementation in

122 viously reported that high concentrations of basic fibroblast growth factor (bFGF) support feeder-ind

123 duced with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) to generate neural

124 The BMP antagonist noggin synergizes with basic fibroblast growth factor (bFGF) to repress BMP sig

125 This effect was rescued by the addition of basic fibroblast growth factor (bFGF) to the culture med

126 Cytokine array analysis showed that basic fibroblast growth factor (bFGF) was downregulated

127 Basic fibroblast growth factor (bFGF) was immobilized by

128 Basic fibroblast growth factor (bFGF) was used to induce

129 erences in angiogenic factors, the levels of basic fibroblast growth factor (bFGF) were compared with

130 with high-dose (80 ng) or low-dose (12.5 ng) basic fibroblast growth factor (bFGF) were placed in BAL

131 astasis is linked to increased production of basic fibroblast growth factor (bFGF), a powerful mitoge

132 s was induced on 10-day-old chick embryos by basic fibroblast growth factor (bFGF), and areas of neov

133 ransforming growth factor beta1 (TGF-beta1), basic fibroblast growth factor (bFGF), and epidermal gro

134 ntaining vascular endothelial growth factor, basic fibroblast growth factor (bFGF), and heparin to dr

135 rations of leukemia inhibitory factor (LIF), basic fibroblast growth factor (bFGF), and nerve growth

136 ignaling induced by epidermal growth factor, basic fibroblast growth factor (bFGF), and platelet-deri

137 le factor 1alpha (Hif-1alpha), Snail1, Slug, basic fibroblast growth factor (bFgf), and retinaldehyde

138 f vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and their recepto

139 tude of this effect to the angiogenic factor basic fibroblast growth factor (bFGF), and to investigat

140 ssion of matrix metalloproteinase-2 (MMP-2), basic fibroblast growth factor (bFGF), and vascular endo

141 so prevented the activation of NF-kappa B by basic fibroblast growth factor (bFGF), angiotensin-II (A

142 SMCs, when stimulated with thrombin, release basic fibroblast growth factor (bFGF), causing phosphory

143 lso the fourth ventricles and, together with basic fibroblast growth factor (bFGF), elicited subseque

144 ascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), generated enthusi

145 g vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), insulin-like grow

146 f vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), interleukin-1 rec

147 nalyses were used to determine the levels of basic fibroblast growth factor (bFGF), neuronal nitric o

148 release polygalactone polymer rod containing basic fibroblast growth factor (bFGF), no growth factor

149 When cultured in the presence of basic fibroblast growth factor (bFGF), NPCs express the

150 a with stromal-derived factor-1alpha (SDF1), basic fibroblast growth factor (bFGF), or bone morphogen

151 f vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), placental growth

152 onic (E14) mice were initially cultured with basic fibroblast growth factor (bFGF), Sonic hedgehog, a

153 on factors epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), suggesting that P

154 and significantly affected the expression of basic fibroblast growth factor (bFGF), vascular endothel

155 etion (24 h) of tumor necrosis factor-alpha, basic fibroblast growth factor (bFGF), vascular endothel

156 or type 1 (FGFR-1), and a minority exhibited basic fibroblast growth factor (bFGF), whereas few expre

157 ascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which in turn, in

158 the effects of cyclooxygenase inhibitors on basic fibroblast growth factor (bFGF)- and vascular endo

159 Treatment of basic fibroblast growth factor (bFGF)-expanded neurosphe

160 process, integrin alphavbeta3 is specific to basic fibroblast growth factor (bFGF)-induced angiogenes

161 type-1 matrix metalloproteinase (MT1-MMP) on basic fibroblast growth factor (bFGF)-induced corneal ne

162 helial cell apoptosis but strongly inhibited basic fibroblast growth factor (bFGF)-induced endothelia

163 The effect of AR inhibition on basic fibroblast growth factor (BFGF)-induced mitogenic

164 ed that ephrinB1 and EphB1 were expressed in basic fibroblast growth factor (bFGF)-induced vasculariz

165 scular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-mediated angiogeni

166 othelial cells, JAM-A has been implicated in basic fibroblast growth factor (bFGF)-regulated angiogen

167 nd latent antithrombins was observed in both basic fibroblast growth factor (bFGF)-stimulated and uns

168 ibitor (JW74), in the presence or absence of basic fibroblast growth factor (bFGF).

169 extract (BPE), nerve growth factor (NGF), or basic fibroblast growth factor (bFGF).

170 nt with several growth factors, most notably basic fibroblast growth factor (bFGF).

171 activation of ERK induced by endothelin-1 or basic fibroblast growth factor (bFGF).

172 lar endothelial growth factor-A (VEGF-A) and basic fibroblast growth factor (bFGF).

173 scular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF).

174 A primary mediator of angiogenesis is basic fibroblast growth factor (bFGF).

175 , which was purified and identified by MS as basic fibroblast growth factor (bFGF).

176 scular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF).

177 ion of CD13/APN transcription in response to basic fibroblast growth factor (bFGF).

178 ds (NDs) as a delivery vehicle for BMP-2 and basic fibroblast growth factor (bFGF).

179 and medulloblastoma cells can be blocked by basic fibroblast growth factor (bFGF).

180 ulture, which is escalated in the absence of basic fibroblast growth factor (bFGF).

181 ) reduced angiogenic sprouting stimulated by basic fibroblast growth factor (bFGF); (b) inhibited mat

182 ommon proangiogenic factors [PAF; VEGF-A and basic fibroblast growth factor (bFGF)].

183 ivin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2

184 injection of KA alone or in combination with basic fibroblast growth factor (bFGF, intracerebroventri

185 tment was associated with decrease in plasma basic fibroblast growth factor (bFGF; P = .04) and incre

186 involved in cartilage homeostasis, including basic fibroblast growth factors (bFGF or FGF-2), transfo

187 ascular endothelial growth factor (VEGF) and basic fibroblasts growth factor (bFGF), indicating an in

188 es can bind to heparin-binding proteins (eg, basic fibroblast growth factor [bFGF] but not vascular e

189 As multiple angiogenic factors (VEGF and basic fibroblast growth factor [bFGF]) play a role in pr

190 ial growth factor [VEGF], interleukin-8, and basic fibroblast growth factor [bFGF]) were determined b

191 cytokines platelet-derived growth factor or basic fibroblast growth factor, both of which also stimu

192 of the common proangiogenic factors VEGF and basic fibroblast growth factor but rather induced expres

193 ors, vascular endothelial growth factor, and basic fibroblast growth factor by regulating IkappaBalph

194 rowth factor; (b) fibroblast growth factor 2/basic fibroblast growth factor; (c) interleukin (IL)-1al

195 lar endothelial growth factor (VEGF) but not basic fibroblast growth factor can induce gene expressio

196 exact test P < 0.015) and reduction in urine basic fibroblast growth factor concentration.

197 esis inhibitor), or for thrombospondin-1 and basic fibroblast growth factor, confirms the segregation

198 viously shown that a truncated form of 24-kd basic fibroblast growth factor consisting of the amino t

199 To determine whether 24kD basic fibroblast growth factor could be modified to elim

200 neprilysin, resulted in a slight increase in basic fibroblast growth factor electrophoretic mobility

201 well a robust mitogenic response of ASCs to basic fibroblast growth factor, epidermal growth factor,

202 riments demonstrated that only PDGF, and not basic fibroblast growth factor, epidermal growth factor,

203 Other growth factors, including basic fibroblast growth factor, epidermal growth factor,

204 ied as a potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC(50) = 1

205 Basic fibroblast growth factor (FGF) promotes branching

206 cells (CECs) are simultaneously treated with basic fibroblast growth factor (FGF)-2 and RhoA inhibito

207 porcine aortic valve leaflets, we show that basic fibroblast growth factor (FGF-2) effectively block

208 Basic fibroblast growth factor (FGF-2) has been reported

209 The binding of basic fibroblast growth factor (FGF-2) to its cell surfa

210 ost angiogenic factors, we demonstrated that basic fibroblast growth factor (FGF-2) was a major cytok

211 fter stroke, levels of the 50-kD heparanase, basic fibroblast growth factor (FGF-2), and angiopoietin

212 reas steady-state hematopoiesis is normal in basic fibroblast growth factor (FGF-2)-knockout mice, pa

213 ties were analyzed in saliva samples; NO and basic fibroblast growth factor (FGF-b) levels were analy

214 ophage migration inhibition factor (MIF) and basic fibroblast growth factor (FGF-basic) cytokines tha

215 ulation of beta-chemokines (CCL2 and CCL22), basic fibroblast growth factor (FGF-basic), hepatocyte g

216 zebrafish leukemia inhibitory factor (Lif), basic fibroblast growth factor (Fgf2) and glial-cell-lin

217 Immunohistochemistry for BrdU and basic fibroblast growth factor (FGF2) and in situ hybrid

218 ing approach to identify QTLs that influence basic fibroblast growth factor (FGF2) induced neovascula

219 Basic fibroblast growth factor (Fgf2) is required for th

220 Basic fibroblast growth factor (FGF2) suppresses the gro

221 T4 and basic fibroblast growth factor (FGF2) were comparably ef

222 essant treatments increase the expression of basic fibroblast growth factor (FGF2), a polypeptide gro

223 onditions included, but were not limited to, basic fibroblast growth factor (FGF2), heparin-binding E

224 ascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF2), were previously i

225 vascular endothelial cell growth factor and basic fibroblast growth factor further decreased miR-223

226 , and vascular endothelial growth factor and basic fibroblast growth factor gene expression that is i

227 Activin A, bone morphogenetic protein 4, and basic fibroblast growth factor) generated CMs with high

228 red with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimu

229 n > EGF > heparin binding (HB)-EGF > IGF-1 > basic fibroblast growth factor >IL-8 > HGF > IL-1 > KGF>

230 ic factor (BDNF) expression but not VEGF and basic fibroblast growth factor in the ischemic brain com

231 ch as vascular endothelial growth factor and basic fibroblast growth factor in these osteogenic proge

232 tor, monocyte chemoattractant protein-1, and basic fibroblast growth factor in this cell type.

233 hydrogenase II, vascular endothelial factor, basic fibroblast growth factor) in the context of human

234 cular endothelial growth factor (VEGF)-C and basic fibroblast growth factor increased in VR1814-infec

235 hibit vascular endothelial growth factor- or basic fibroblast growth factor-induced angiogenesis at c

236 scular endothelial growth factor-induced and basic fibroblast growth factor-induced angiogenesis at m

237 ir conditional ablation completely abrogated basic fibroblast growth factor-induced angiogenesis in M

238 epressor of NF-kappa B, I kappa B-2A, blocks basic fibroblast growth factor-induced angiogenesis in v

239 administered i.p. by osmotic pump inhibited basic fibroblast growth factor-induced angiogenesis in W

240 28.6 microM, and it significantly inhibited basic fibroblast growth factor-induced angiogenesis on t

241 not mitogenic on its own, CCN3 also enhances basic fibroblast growth factor-induced DNA synthesis.

242 eral injection of Marimastat also suppressed basic fibroblast growth factor-induced endothelial-mesen

243 monstrate that SPARC significantly increases basic fibroblast growth factor-induced fibroblast migrat

244 on and apoptosis but significantly inhibited basic fibroblast growth factor-induced fibroblast migrat

245 In vitro studies showed that basic fibroblast growth factor-induced human umbilical v

246 hich vascular endothelial growth factor- and basic fibroblast growth factor-induced neovacularization

247 r endothelial cell growth factor-induced and basic fibroblast growth factor-induced phosphorylation o

248 r endothelial cell growth factor-induced and basic fibroblast growth factor-induced proliferation, as

249 both vascular endothelial growth factor- and basic fibroblast growth factor-induced tissue plasminoge

250 ial growth factor, hepatocyte growth factor, basic fibroblast growth factor), inflammatory factors (i

251 The 24-kDa form of basic fibroblast growth factor inhibits the migration of

252 cular endothelial cells (HMVECs) mediated by basic fibroblast growth factor, insulin-like growth fact

253 HMVECs cultured with a combination of basic fibroblast growth factor, insulin-like growth fact

254 nd in response to angiogenic factors such as basic fibroblast growth factor, interleukin-8, tumor nec

255 emonstrates that the truncated form of 24-kd basic fibroblast growth factor is effective in suppressi

256 LD22-4, an 86-amino acid fragment of the basic fibroblast growth factor, is an inhibitor of cell

257 n 6, vascular endothelial growth factor, and basic fibroblast growth factor, known to be highly expre

258 ormal vascular endothelial growth factor and basic fibroblast growth factor levels, implying an essen

259 ll-vascular endothelial growth factor (VEGF)/basic fibroblast growth factor Matrigel plug assay, in w

260 porcine aortic endothelial cell (PAEC)-VEGF/basic fibroblast growth factor-Matrigel implants in nude

261 necessary to down-regulate the expression of basic fibroblast growth factor, matrix metalloprotease-9

262 Changes in plasma placental growth factor, basic fibroblast growth factor, matrix metalloproteinase

263 tube formation in response to both VEGF- and basic fibroblast growth factor-mediated angiogenic stimu

264 y of EphA2/Fc soluble receptors against VEGF/basic fibroblast growth factor-mediated neovascularizati

265 partially scrambled mutant aptamer inhibited basic fibroblast growth factor-mediated neovascularizati

266 ic neuronal responses after a combination of basic fibroblast growth factor, neurotrophin-3 and brain

267 Reconstitution with exogenous basic fibroblast growth factor normalized patient MSC pr

268 g purified angiogenic growth factors such as basic fibroblast growth factor or vascular endothelial g

269 stromal cell-derived factor-1alpha, but not basic fibroblast growth factor or vascular endothelial g

270 s impregnated with an angiogenic stimulator (basic fibroblast growth factor or vascular endothelial g

271 3 at nanomolar concentrations inhibit either basic fibroblast-growth-factor or sphingosine-1-phosphat

272 nt increased compared to baseline, including basic fibroblast growth factor (P = .046), hepatocyte gr

273 uced by the profibrotic growth factors (GFs) basic fibroblast growth factor, platelet-derived growth

274 Basic fibroblast growth factor potentiated the self-rene

275 ofibrotic ontologies associated with reduced basic fibroblast growth factor production, which was con

276 In cultured endothelial cells, VEGF, but not basic fibroblast growth factor, promotes the Src-mediate

277 ctors (brain-derived neurotrophic factor and basic fibroblast growth factor), protein chaperones (hea

278 factor (VEGF), VEGF receptor 1 (Flt-1), and basic fibroblast growth factor proteins were higher in t

279 expression of nerve growth factor (NGF) and basic fibroblast growth factor, sensory axons were able

280 roteins (eg, platelet-derived growth factor, basic fibroblast growth factor) sequestered by platelets

281 esulted in an increased and sustained bFGF2 (basic fibroblast growth factor) signaling and promoted c

282 In vitro analyses suggest that Shp2 mediates basic fibroblast growth factor signals in stimulating se

283 on of a combination of three growth factors, basic fibroblast growth factor, stem cell factor, and en

284 noma cell adhesion, migration, invasion, and basic fibroblast growth factor stimulated proliferation

285 imulated chick chorioallantoic membranes and basic fibroblast growth factor-stimulated mouse corneas.

286 alternative pro-angiogenic factors, such as basic fibroblast growth factor, stromal-derived factor-1

287 d to generate mMSCs by utilizing hypoxia and basic fibroblast growth factor supplementation.

288 we studied MC/Mph migration and assembly in basic fibroblast growth factor-supplemented Matrigel plu

289 rotrophic factor-family receptor alpha-1 and basic fibroblast growth factor supports proliferation of

290 dothelial cells was up-regulated by VEGF and basic fibroblast growth factor synergistically, and by h

291 TAT3 signalling, but they respond to activin/basic fibroblast growth factor to form self-renewing epi

292 growth in the absence of serum, but require basic fibroblast growth factor to remain undifferentiate

293 h vascular endothelial growth factor or with basic fibroblast growth factor to stimulate DNA synthesi

294 of soluble GDNF-family receptor alpha-1 and basic fibroblast growth factor to support replication.

295 growth factors (hepatocyte growth factor and basic fibroblast growth factor) to induce mammary acini

296 mers of epidermal growth factor receptor and basic fibroblast growth factor, two glycoproteins known

297 Baseline cotinine, basic fibroblast growth factor, vascular endothelial gro

298 ation and decreased migration in response to basic fibroblast growth factor when compared with WT cel

299 inases (MMP)-2, MMP-3, MMP-7, and MMP-9, and basic fibroblast growth factor, which play crucial roles

300 um [termed hESC Cocktail (HESCO)] containing basic fibroblast growth factor, Wnt3a, April (a prolifer